Skip to main content

What's new

diaTribe partnered with Abbott and Novo Nordisk to bring you the Time in Range Hub – a new online resource to help you and your healthcare providers learn about Time in Range. Read more about this exciting new website below.  Continue Reading »

Researchers are investigating if increasing positive affect – the feelings of being happy, cheerful, or proud of your accomplishments – can help teens with type 1 diabetes develop more adaptive coping strategies for their diabetes distress. Continue Reading »

Quality measures are tools to evaluate the effectiveness and quality of healthcare. Measures such as A1C, blood pressure, and cholesterol are used to understand health at the population level to ensure people with diabetes are getting the best care possible. At The diaTribe Foundation, we believe that Time in Range would be a valuable addition to the quality measures for diabetes care. Continue Reading »

Curious to know what apps are available to you to help you manage a variety of health conditions? At the ADCES 2021 conference, experts discussed the best options out there from diabetes prevention to weight management to exercise and more. Continue Reading »

A survey jointly conducted by diabetes research company dQ&A and The diaTribe Foundation assessed how well endocrinologists understood Time in Range and which diabetes metrics they consider most important for setting treatment goals. Continue Reading »

The Association of Diabetes Care and Education Specialists 2021 conference covered the impacts of diabetes stigma, smart MDI therapies, insulin delivery by means other than an insulin pump, the latest in diabetes tech, and more! Continue Reading »

Abbott has released a new iPhone app for its FreeStyle Libre 2 which offers several important upgrades, including improved remote monitoring, which helps people with diabetes and healthcare professionals. Continue Reading »

Ascensia Diabetes Care just launched a new Patient Assistance Program, which is now available in the US. The program aims to reduce out-of-pocket expenses for those who are starting or already using Senseonics’ Eversense 90-day implantable continuous glucose monitoring system. Continue Reading »

Pages